Evidence map›Paper›PMID 31206088›Full record

ArticleHeliyon2019

Antifungal spectrum characterization and identification of strong volatile organic compounds produced by

Toshiyuki Morita, Issei Tanaka, Noriko Ryuda, Masao Ikari, Daisuke Ueno, Takashi Someya

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Article
  7. Antifungal effect and some properties of cell-free supernatants of two Bacillus subtilis isolates against Fusarium verticillioides.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  8. Unveiling the Potential ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Article
  11. Antibiotics (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Biocontrol of fungal phytopathogens byFrontiers in microbiology · 2023
    Review
  14. Article
  15. Isolation and identification of antagonisticFrontiers in microbiology · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Air Ambulance: Antimicrobial Power of Bacterial Volatiles.Antibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Toshiyuki MoritaDepartment of Environmental Biosciences, Faculty of Agriculture, Saga University, Japan.
Issei TanakaDepartment of Environmental Biosciences, Faculty of Agriculture, Saga University, Japan.
Noriko RyudaDepartment of Environmental Biosciences, Faculty of Agriculture, Saga University, Japan.
Masao IkariT.M Enterprise Ltd., Japan.
Daisuke UenoDepartment of Environmental Biosciences, Faculty of Agriculture, Saga University, Japan.
Takashi SomeyaDepartment of Environmental Biosciences, Faculty of Agriculture, Saga University, Japan.
Kagoshima University · JPSaga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To obtain biocontrol agents for suppression of food-deteriorating fungi during storage of agricultural products, bacteria producing volatile organic compounds (VOCs) with strong antifungal activity were screened and isolated from various environmental samples. Among 136 bacterial isolates, strain TM-R showed the strongest and broadest antifungal activity. Based on physiological and genetical characterization, the bacterium was identified as

Indexed as

AgricultureBiotechnologyMicrobiology

Identifiers

PMID31206088
PMCPMC6558263
OpenAlexW2949656274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.